BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21397156)

  • 1. [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Bernard P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):259-63. PubMed ID: 21397156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S; Joly P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):247-51. PubMed ID: 21397154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pemphigoid gestationis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Ingen-Housz-Oro S; Bedane C; Prost C; Joly P; Bernard P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):264-6. PubMed ID: 21397157
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Prost-Squarcioni C; Ingen-Housz-Oro S; Joly P; Bernard P; Bedane C;
    Ann Dermatol Venereol; 2011 Mar; 138(3):274-9. PubMed ID: 21397160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Linear IgA dermatosis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Ingen-Housz-Oro S; Bernard P; Bedane C; Prost C; Joly P;
    Ann Dermatol Venereol; 2011 Mar; 138(3):267-70. PubMed ID: 21397158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Joly P; Bernard P; Bedane C; Prost C; Ingen-Housz-Oro S;
    Ann Dermatol Venereol; 2011 Mar; 138(3):252-8. PubMed ID: 21397155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dermatitis herpetiformis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
    Ingen-Housz-Oro S; Joly P; Bernard P; Bedane C; Prost C;
    Ann Dermatol Venereol; 2011 Mar; 138(3):271-3. PubMed ID: 21397159
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of mucous membrane pemphigoid with infliximab.
    Heffernan MP; Bentley DD
    Arch Dermatol; 2006 Oct; 142(10):1268-70. PubMed ID: 17043180
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
    Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
    J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune blistering diseases].
    Amagai M
    Nihon Rinsho; 2005 May; 63 Suppl 5():540-6. PubMed ID: 15954407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucous membrane pemphigoid: a review].
    Bédane C; Doffoel Hantz V
    Ann Dermatol Venereol; 2011 Mar; 138(3):201-8. PubMed ID: 21397149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.
    Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S
    Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in mucous membrane pemphigoid.
    Daniel E; Thorne JE
    Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of mucous membrane pemphigoid and pemphigus.
    Knudson RM; Kalaaji AN; Bruce AJ
    Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign mucous membrane pemphigoid with advanced periodontal involvement: diagnosis and therapy.
    Lilly JP; Spivey JD; Fotos PG
    J Periodontol; 1995 Aug; 66(8):737-41. PubMed ID: 7473017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of mucous membrane pemphigoid. Results of the 1st International Consensus Conference].
    Hautarzt; 2002 May; 53(5):371-2. PubMed ID: 12063752
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral mucous membrane pemphigoid: complete response to topical tacrolimus.
    Lee HY; Blazek C; Beltraminelli H; Borradori L
    Acta Derm Venereol; 2011 Sep; 91(5):604-5. PubMed ID: 21597668
    [No Abstract]   [Full Text] [Related]  

  • 20. Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used?
    Maglie R; Borgi A; Caproni M; Antiga E
    Br J Dermatol; 2019 May; 180(5):1266-1267. PubMed ID: 30693475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.